Table 1.
SBA | PBA | |
---|---|---|
Characteristics | HR (95%CI), p-value | HR (95%CI), p-value |
Race | ||
White | referent | referent |
Black | 0.97 (0.40–2.39), 0.953 | 1.50 (0.65–3.48), 0.346 |
Other (American Indian/ AK Native, Asian/ Pacific Islander) | 0.85 (0.31–2.31), 0.746 | 0.86 (0.39–1.88), 0.698 |
Age at Diagnosis | ||
Continuous | 1.05 (1.03–1.06), <0.001 | 1.01 (1.00–1.02), 0.054 |
Size | ||
Continuous | 1.00 (1.00–1.01), 0.036 | 1.01 (1.01–1.01), <0.001 |
Tumor Grade | ||
I | 0.32 (0.11–0.89), 0.030 | 0.37 (0.17–0.78), 0.010 |
II | 0.83 (0.44–1.59), 0.582 | 0.35 (0.17–0.70), 0.003 |
III | 0.92 (0.56–1.49), 0.730 | 1.09 (0.58–2.05), 0.972 |
IV | referent | referent |
Missing | 0.79 (0.49–1.28), 0.340 | 0.39 (0.15–0.98), 0.046 |
Lymph node involvement | ||
Negative | referent | referent |
Positive | 2.14 (0.67–6.82), 0.197 | 3.29 (1.30–8.30), 0.012 |
Unknown | 1.52 (0.90–2.56), 0.120 | 1.19 (0.58–2.41), 0.637 |
Tumor Stage | ||
Local | referent | referent |
Regional | 1.92 (1.31–2.82), 0.001 | 3.15 (1.84–5.40), <0.001 |
Primary Site | ||
Nipple | 2.11 (0.76–5.83), 0.152 | n/a |
Central portion of breast | 1.46 (0.76–2.79), 0.252 | 0.78 (0.18–3.30), 0.736 |
Upper-inner quadrant of breast | 0.84 (0.21–3.46), 0.815 | 0.35 (0.12–1.01), 0.052 |
Lower- inner quadrant of breast | 1.62 (0.64–4.05), 0.306 | 0.37 (0.11–1.23), 0.104 |
Upper- outer quadrant of breast | 0.47 (0.19–1.18), 0.107 | 0.55 (0.25–1.22), 0.140 |
Lower- outer quadrant of breast | 1.11 (0.45–2.78), 0.820 | 0.33 (0.04–2.42), 0.275 |
Overlapping lesion of breast | 1.42 (0.87–2.30), 0.161 | 1.06 (0.62–1.82), 0.831 |
Breast, NOS | referent | referent |
Radiation | ||
No/Unknown | referent | referent |
Yes | 0.72 (0.35–1.48), 0.374 | 1.21 (0.74–1.96), 0.445 |
Chemotherapy | ||
No/Unknown | referent | referent |
Yes | 0.76 (0.47–1.21), 0.240 | 1.14 (0.68–1.90), 0.627 |